CompletedInterventionalPhase 2Last updated Sep 16, 2011

Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

Pilot Trial of Treatment of Poor-Prognosis IgA Nephropathy With Low Exposure to Sirolimus.

Overview

ClinicalTrials.gov ID: NCT00396721
Lead Sponsor: Josep m CruzadoOTHER
Brief Summary: The purpose of this study is to test in a pilot trial the efficacy and tolerance of sirolimus oral (at low doses) in patient to treat poor-prognosis IgA Nephropathy.
Study Type: Interventional

Status

Study Record Dates

NCT04892212Unknown status

Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis

NCT00050713Completed

Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy

NCT00167947Completed

Study Evaluating Sirolimus in Kidney Transplant Recipients.

NCT00095329Terminated

Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor

NCT00282217Completed

Study Evaluating Sirolimus in the Treatment of Kidney Transplant

NCT00450320Completed

Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma